Cargando…

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II

SIMPLE SUMMARY: Organometallics, such as copper compounds, are cancer chemotherapeutics used alone or in combination with other drugs. One small group of copper complexes exerts an effective inhibitory action on topoisomerases, which participate in the regulation of DNA topology. Copper complexes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molinaro, Caroline, Martoriati, Alain, Pelinski, Lydie, Cailliau, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601307/ https://www.ncbi.nlm.nih.gov/pubmed/33027952 http://dx.doi.org/10.3390/cancers12102863

Ejemplares similares

A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
por: Molinaro, Caroline, et al.
Publicado: (2022)

Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor
por: Molinaro, Caroline, et al.
Publicado: (2023)

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
por: Molinaro, Caroline, et al.
Publicado: (2021)

Effects of Ferrocenyl 4-(Imino)-1,4-Dihydro-quinolines on Xenopus laevis Prophase I - Arrested Oocytes: Survival and Hormonal-Induced M-Phase Entry
por: Marchand, Guillaume, et al.
Publicado: (2020)

Another Facet to the Anticancer Response to Lamellarin D: Induction of Cellular Senescence through Inhibition of Topoisomerase I and Intracellular Ros Production
por: Ballot, Caroline, et al.
Publicado: (2014)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
por: Okoro, Cosmas O., et al.
Publicado: (2023)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Diversity of sialic acids and sialoglycoproteins in gametes and at fertilization
por: Fliniaux, Ingrid, et al.
Publicado: (2022)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011)

Follicular cells protect Xenopus oocyte from abnormal maturation via integrin signaling downregulation and O-GlcNAcylation control
por: Martoriati, Alain, et al.
Publicado: (2023)

Copper(II) N,N,O-Chelating Complexes as Potential Anticancer Agents
por: Peña, Quim, et al.
Publicado: (2021)

Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes
por: Ribeiro, Nádia, et al.
Publicado: (2023)

Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme
por: Swedan, Hadeer K., et al.
Publicado: (2022)

Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
por: Cowell, Ian G., et al.
Publicado: (2012)

Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents
por: Ayyamperumal, Selvaraj, et al.
Publicado: (2021)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation
por: González-Ruiz, Víctor, et al.
Publicado: (2021)

Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies
por: Hussain, Afzal, et al.
Publicado: (2019)

Targeting DNA Topoisomerase II in Antifungal Chemotherapy
por: Kondaka, Kavya, et al.
Publicado: (2022)

Liposomal formulations of anticancer copper(ii) thiosemicarbazone complexes
por: Mathuber, Marlene, et al.
Publicado: (2021)

Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
por: Alvarez, Natalia, et al.
Publicado: (2023)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
por: Xu, Yang, et al.
Publicado: (2015)

Hydrogen Sulfide Impairs Meiosis Resumption in Xenopus laevis Oocytes
por: Gelaude, Armance, et al.
Publicado: (2020)

Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I – DNA Complex
por: Mancini, Giordano, et al.
Publicado: (2010)

Synthesis and Characterization of the Nanogold-Bound Ternary Copper(II) Complex of Phenanthroline and Cysteine as Potential Anticancer Agents
por: Junaid, Ahmad, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Novel 1H-Benzo[d]imidazole Derivatives as Potential Anticancer Agents Targeting Human Topoisomerase I
por: Pandey, Stuti, et al.
Publicado: (2022)

QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
por: Alam, Sarfaraz, et al.
Publicado: (2014)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
por: Chan, Agnes L.-F., et al.
Publicado: (2009)

Validation data supporting the characterization of novel copper complexes as anticancer agents
por: Acilan, Ceyda, et al.
Publicado: (2016)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Anticancer Function and ROS-Mediated Multi-Targeting Anticancer Mechanisms of Copper (II) 2-hydroxy-1-naphthaldehyde Complexes
por: Khan, Muhammad Hamid, et al.
Publicado: (2019)

Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
por: Xu, Huanli, et al.
Publicado: (2016)

Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I
por: Yang, Zhaoqi, et al.
Publicado: (2017)

Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016)

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
por: Ezoe, Sachiko
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qcumlpga5fasotufmtj7oj1ftc